NCT06300151

Brief Summary

Ultrasound real-time guidance technology has great advantages over traditional blind exploration technology in terms of accuracy, success rate, and reduction of puncture damage in intervertebral space positioning through operational visualization, greatly improving the effectiveness and safety of spinal block. At present, Doppler ultrasound is rarely used for spinal block, especially for real-time ultrasound guidance technology, which has not been widely applied in clinical practice due to its high equipment requirements, lack of mature puncture plans, complex operation, and high learning curve. If a comprehensive diagnosis and treatment plan can be developed, it will greatly improve the delivery experience of mothers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
212

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 30, 2026

Status Verified

July 1, 2026

Enrollment Period

1.8 years

First QC Date

March 1, 2024

Last Update Submit

July 28, 2026

Conditions

Keywords

Ultrasound Real-time Guidancelabor analgesiadelivery womanneonateEffectivenessSafety

Outcome Measures

Primary Outcomes (1)

  • Composite endpoint of labor analgesia outcome

    The primary outcome is a binary composite endpoint: "satisfactory" (Grades I-II) versus "unsatisfactory" (Grades III-IV). Grading followed a hierarchical rule (IV \> III \> II \> I): if more than one grade applied, the highest (worst) was assigned. Grade I (best): vaginal delivery (spontaneous or instrumental) with analgesic onset ≤ 20 min, mean VAS ≤ 40 mm, no catheter or protocol adjustment, and modified Bromage score \< 2. Grade II (good): vaginal delivery not meeting Grade I criteria but with onset ≤ 30 min, mean VAS ≤ 60 mm, and no Grade IV-listed complications. Grade III (poor): cesarean delivery, or onset \> 30 min, or mean VAS \> 60 mm. Grade IV (worst): serious analgesia-related complications (unintended dural puncture with the epidural needle, Bromage score ≥ 2, persistent neurological injury, local anesthetic toxicity, or severe hypotension requiring intervention).

    From initiation of labor analgesia to delivery (assessed up to 24 hours).

Secondary Outcomes (26)

  • Time to analgesia onset

    Within 30 minutes after initial drug administration.

  • Visual Analogue Scale (VAS) score

    From initiation of labor analgesia to delivery (assessed up to 24 hours).

  • Number of patient-controlled analgesia (PCA) demands

    From initiation of labor analgesia to delivery (assessed up to 24 hours).

  • Local anesthetic consumption

    From initiation of labor analgesia to delivery (assessed up to 24 hours).

  • Sensory blockade level

    During the labor analgesia period (assessed up to 24 hours).

  • +21 more secondary outcomes

Study Arms (2)

Ultrasound Real-time Guidance combined with Dural Puncture Epidural Group

EXPERIMENTAL

Ultrasound real-time guidance combined with dural puncture epidural Can improve the clinical effect of labor analgesia.

Device: Ultrasound Real-time Guidance combined with Dural Puncture Epidural Labor Analgesia

Dural Puncture Epidural Group

ACTIVE COMPARATOR

Dural Puncture Epidural is a clinical improvement of Combined Spinal-Epidural and is widely used in Maternal. The implementation step is to complete the epidural puncture, temporarily do not place a tube, puncture the dura mater with a subarachnoid anesthesia needle, but do not directly inject drugs into the subarachnoid space, and then leave an epidural catheter for administration according to epidural block.

Device: Dural Puncture Epidural Labor Analgesia

Interventions

Ultrasound real-time guidance technology has great advantages over traditional blind exploration technology in terms of accuracy, success rate, and reduction of puncture damage in intervertebral space positioning through operational visualization, greatly improving the effectiveness and safety of spinal block.

Ultrasound Real-time Guidance combined with Dural Puncture Epidural Group

Dural Puncture Epidural is a clinical improvement of Combined Spinal-Epidural and is widely used in Maternal. The implementation step is to complete the epidural puncture, temporarily do not place a tube, puncture the dura mater with a subarachnoid anesthesia needle, but do not directly inject drugs into the subarachnoid space, and then leave an epidural catheter for administration according to epidural block.

Dural Puncture Epidural Group

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) Class I or II;
  • Single healthy pregnancy;
  • Head showing first;
  • to 41 weeks;
  • The labor process is active, and the cervix dilates\<5cm;
  • Require epidural labor analgesia;
  • Volunteer to participate in this study and sign an informed consent form.

You may not qualify if:

  • Presence of pregnancy diseases, such as pregnancy hypertension, pre eclampsia, pregnancy diabetes;
  • Contraindications to intraspinal analgesia: 1) Central nervous system diseases. 2) Infection or septicemia at the puncture site. 3) Coagulation dysfunction;
  • Known cases of fetal malformation or increased risk of cesarean section, such as a history of uterine rupture;
  • Persons with a history of mental illness, hysteria, epilepsy, etc. who cannot cooperate.
  • Patients with long-term use of opioids, steroids, and chronic pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Provincial Hospital

Fuzhou, Fujian, 350001, China

Location

Study Officials

  • Zongxun Lin, Master

    Fujian Provincial Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 8, 2024

Study Start

April 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

July 30, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations